Nu-Med Plus (NUMD) Enterprise Value Growth (5y) (2016 - 2025)
Nu-Med Plus (NUMD) Enterprise Value Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 67.72% |
| Sep 30, 2025 | 42.69% |
| Jun 30, 2025 | 32.38% |
| Mar 31, 2025 | 33.56% |
| Dec 31, 2024 | 19.64% |
| Sep 30, 2024 | 37.34% |
| Jun 30, 2024 | 23.76% |
| Mar 31, 2024 | 22.86% |
| Dec 31, 2023 | 47.31% |
| Sep 30, 2023 | 41.95% |
| Jun 30, 2023 | 36.42% |
| Mar 31, 2023 | 28.07% |
| Dec 31, 2022 | 26.92% |
| Sep 30, 2022 | 72.64% |
| Mar 31, 2022 | 61.89% |
| Dec 31, 2021 | 1.28% |
| Sep 30, 2021 | -87.25% |
| Jun 30, 2021 | -14.00% |
| Mar 31, 2021 | -9.71% |
| Dec 31, 2020 | -43.57% |